Drugs Made In America Acquisition (DMAAR) Change in Accured Expenses (2025)
Drugs Made In America Acquisition (DMAAR) posted Change in Accured Expenses of -$80439.0 for Q4 2025, down 151.84% on a QoQ basis from $155170.0 in Q3 2025.
Drugs Made In America Acquisition (DMAAR) Change in Accured Expenses (2025) Analysis & Trends
Drugs Made In America Acquisition's Change in Accured Expenses history runs 1 years deep, the most recent figure standing at -$80439.0 for Q4 2025.
- Quarterly Change in Accured Expenses changed N/A year-over-year to -$80439.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $144904.0 (changed N/A YoY) and the FY2025 annual result came in at $144904.0, up 87.51% from the prior year.
- Change in Accured Expenses was -$80439.0 for Q4 2025 at Drugs Made In America Acquisition, down from $155170.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $155170.0 in Q3 2025 and bottomed at -$80439.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | SIM Acquisition Corp. I | 314.52 Mn | 314.52 Mn | - | -238,633.00 |
| 2 | Thayer Ventures Acquisition | 208.29 Mn | 208.29 Mn | - | -26,114.00 |
| 3 | Newbury Street II Acquisition | 185.26 Mn | 185.26 Mn | - | -20,182.00 |
| 4 | Dynamix | 179.28 Mn | 179.28 Mn | - | 262,799.00 |
| 5 | Hallmark Venture | 103.01 Mn | 102.76 Mn | - | -2,294.00 |
| 6 | Voyager Acquisition | 99.58 Mn | 99.45 Mn | - | - |
| 7 | Gores Holdings X | 95.80 Mn | 95.37 Mn | - | - |
| 8 | Archimedes Tech SPAC Partners | 89.63 Mn | 89.63 Mn | - | 8,985.00 |
| 9 | Marblegate Capital | 81.65 Mn | 55.81 Mn | - | -3.83 Mn |
| 10 | Drugs Made In America Acquisition | 1.41 Mn | 1.41 Mn | - | -80,439.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -80,439.00 |
| Dec 31, 2025 | -80,439.00 |
| Sep 30, 2025 | 155,170.00 |
| Sep 30, 2025 | 155,170.00 |
| Jun 30, 2025 | 14,970.00 |
| Jun 30, 2025 | 14,970.00 |
| Mar 31, 2025 | 55,203.00 |
| Mar 31, 2025 | 55,203.00 |